The IMPACCT Real-World Evidence Summit West is set to explore the integration of AI and real-world data in healthcare. The summit aims to address t...
Former FDA commissioner Scott Gottlieb has expressed concerns that the United States is losing its competitive edge in the global biopharmaceutical...
Former FDA Commissioner Scott Gottlieb has expressed concerns that the United States is losing its competitive edge in the global biopharmaceutical...
Bayer has submitted a new MRI contrast agent, gadoquatrane, for FDA review in the U.S. This agent is designed to reduce gadolinium levels, a rare e...
Bayer has submitted a new MRI contrast agent, gadoquatrane, for FDA review in the United States. This agent is designed to reduce the use of gadoli...
PurpleLab Managed Services is offering solutions to streamline clinical trial development by leveraging real-world data and advanced analytics. The...
The Most-Favored Nation (MFN) drug pricing initiative, originally introduced by President Trump, aims to align U.S. drug prices with those in other...
Argenx has announced positive results from its ADAPT SERON trial for Vyvgart (efgartigimod), a treatment for generalized myasthenia gravis (gMG). T...
Argenx, a Netherlands-based pharmaceutical company, has released positive results from its ADAPT SERON trial for Vyvgart (efgartigimod), a drug des...
Sonio, a MedTech company focused on women's and children's health, has introduced a new AI-powered product suite aimed at enhancing maternal health...